Haploidentical Stem Cell Transplantation With CD3/CD19 Depletion and Reduced Intensity Conditioning in Patients With Acute Leukemia

NCT00961142 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

23

Enrollment

OTHER

Sponsor class

Stopped slow recruitment

Conditions

Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia

Interventions

DRUG: Fludarabine, Thiotepa, Melphalan, Thymoglobuline (ATG)

Sponsor

University Hospital Tuebingen